255 related articles for article (PubMed ID: 11241504)
1. Apoptotic index by Annexin V flow cytometry: adjunct to morphologic and cytogenetic diagnosis of myelodysplastic syndromes.
Merchant SH; Gonchoroff NJ; Hutchison RE
Cytometry; 2001 Feb; 46(1):28-32. PubMed ID: 11241504
[TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
[TBL] [Abstract][Full Text] [Related]
3. The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS.
Parker JE; Mufti GJ; Rasool F; Mijovic A; Devereux S; Pagliuca A
Blood; 2000 Dec; 96(12):3932-8. PubMed ID: 11090080
[TBL] [Abstract][Full Text] [Related]
4. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
7. Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro.
Bouscary D; Chen YL; Guesnu M; Picard F; Viguier F; Lacombe C; Dreyfus F; Fontenay-Roupie M
Exp Hematol; 2000 Jul; 28(7):784-91. PubMed ID: 10907640
[TBL] [Abstract][Full Text] [Related]
8. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
9. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Huh YO; Jilani I; Estey E; Giles F; Kantarjian H; Freireich E; Albitar M
Leukemia; 2002 Nov; 16(11):2249-52. PubMed ID: 12399969
[TBL] [Abstract][Full Text] [Related]
10. [Expression of Fas, FasL and Bcl-2 and apoptosis of bone marrow CD34+ cells in patients with myelodysplastic syndrome].
Zhang Z; Xie J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):274-7. PubMed ID: 12844412
[TBL] [Abstract][Full Text] [Related]
11. Increased peripheral stem cell pool in MDS: an indication of disease progression?
Vehmeyer K; Haase D; Alves F
Leuk Res; 2001 Nov; 25(11):955-9. PubMed ID: 11597730
[TBL] [Abstract][Full Text] [Related]
12. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins.
Parker JE; Fishlock KL; Mijovic A; Czepulkowski B; Pagliuca A; Mufti GJ
Br J Haematol; 1998 Dec; 103(4):1075-82. PubMed ID: 9886323
[TBL] [Abstract][Full Text] [Related]
13. Measurement of secondary colony formation after 5 weeks in long-term cultures in patients with myelodysplastic syndrome.
Sato T; Kim S; Selleri C; Young NS; Maciejewski JP
Leukemia; 1998 Aug; 12(8):1187-94. PubMed ID: 9697872
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes in the elderly: the role of growth factors in management.
Saba HI
Leuk Res; 1996 Mar; 20(3):203-19. PubMed ID: 8637215
[TBL] [Abstract][Full Text] [Related]
15. Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome.
Lin CW; Manshouri T; Jilani I; Neuberg D; Patel K; Kantarjian H; Andreeff M; Estrov Z; Beran M; Keating M; Estey E; Albitar M
Leuk Res; 2002 Jun; 26(6):551-9. PubMed ID: 12007503
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous intramedullary apoptosis is present in disorders other than myelodysplasia.
Irvine AE; Magill MK; Somerville LE; McMullin MF
Exp Hematol; 1998 May; 26(5):435-9. PubMed ID: 9590661
[TBL] [Abstract][Full Text] [Related]
18. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
[TBL] [Abstract][Full Text] [Related]
19. Expression and prognostic significance of Bcl-2 family proteins in myelodysplastic syndromes.
Boudard D; Vasselon C; Berthéas MF; Jaubert J; Mounier C; Reynaud J; Viallet A; Chautard S; Guyotat D; Campos L
Am J Hematol; 2002 Jun; 70(2):115-25. PubMed ID: 12111784
[TBL] [Abstract][Full Text] [Related]
20. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
